Skip to main content

Advertisement

Log in

Long-Term Patient-Reported Satisfaction after Contralateral Prophylactic Mastectomy and Implant Reconstruction

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To determine whether satisfaction and health-related quality of life (HR-QoL) differ between women who do and do not undergo contralateral prophylactic mastectomy (CPM) in the setting of implant reconstruction using the BREAST-Q, a validated patient-reported outcome instrument.

Methods

From 2000 to 2007, a total of 3,874 patients with stage 0 to III unilateral breast cancer (BC) had mastectomy; 688 (18 %) pursued CPM within 1 year. Patients who completed the BREAST-Q reconstruction module as part of BREAST-Q validation studies or routine clinical care formed our study cohort. Comparisons were made between CPM and no-CPM patients using univariate analysis and multivariate models (MVA).

Results

Of 294 patients with BREAST-Q data, 112 (38 %) had CPM. Median time from mastectomy to BREAST-Q was 52 months. CPM patients were younger (mean 47 vs. 50 years), more likely to be White (98 vs. 86 %), married (84 vs. 71 %), have a family history of BC (60 vs. 44 %), and to choose silicone implants (67 vs. 48 %). There were no differences in tumor or treatment characteristics between groups at the time of BREAST-Q. Patients with CPM had a higher mean score for Satisfaction with Breasts (64.4 vs. 54.9; p < 0.001) and Satisfaction with Outcome (74.8 vs. 67.7; p = 0.007); other HR-QoL domains did not differ. On MVA, CPM and the absence of lymphedema were significant predictors of Satisfaction with Breasts (CPM p = 0.005, lymphedema p = 0.039). CPM was not associated with improved Satisfaction with Outcome.

Conclusions

This study suggests that in the setting of implant reconstruction, CPM has a positive correlation with patient satisfaction with their breasts, but not with improvements in other HR-QoL domains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–9.

    Article  PubMed  Google Scholar 

  2. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362–7.

    Article  PubMed  Google Scholar 

  3. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17:2554–62.

    Article  PubMed  Google Scholar 

  4. Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2012. doi:10.1097/COC.0b013e318248da47.

  5. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158–64.

    Article  PubMed  Google Scholar 

  6. Chung A, Huynh K, Lawrence C, et al. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19:2600–6.

    Article  PubMed  Google Scholar 

  7. Jones NB, Wilson J, Kotur L, et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6.

    Article  PubMed  Google Scholar 

  8. Yi M, Hunt KK, Arun BK, et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010;3:1026–34.

    Article  PubMed  Google Scholar 

  9. Arrington AK, Jarosek SL, Virnig BA, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.

    Article  PubMed  Google Scholar 

  10. Tuttle TM. Counseling breast cancer patients on contralateral prophylactic mastectomy: the physician’s role. Oncology (Williston Park). 2008;22:545–8.

    PubMed  Google Scholar 

  11. Frost MH, Slezak JM, Tran NV, et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005;23:7849–56.

    Article  PubMed  Google Scholar 

  12. Altschuler A, Nekhlyudov L, Rolnick SJ, et al. Positive, negative, and disparate—women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008;14:25–32.

    Article  PubMed  Google Scholar 

  13. Frost MH, Hoskin TL, Hartmann LC, et al. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011;18:3110–6.

    Article  PubMed  Google Scholar 

  14. Borgen PI, Hill AD, Tran KN, et al. Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol. 1998;5:603–6.

    Article  PubMed  CAS  Google Scholar 

  15. Montgomery LL, Tran KN, Heelan MC, et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6:546–52.

    Article  PubMed  CAS  Google Scholar 

  16. Geiger AM, West CN, Nekhlyudov L, et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006;24:1350–6.

    Article  PubMed  Google Scholar 

  17. Spear SL, Schwarz KA, Venturi ML, et al. Prophylactic mastectomy and reconstruction: clinical outcomes and patient satisfaction. Plast Reconstr Surg. 2008;122:1–9.

    PubMed  CAS  Google Scholar 

  18. Pusic AL, Klassen AF, Scott AM, et al. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124:345–53.

    Article  PubMed  CAS  Google Scholar 

  19. Cano SJ, Klassen AF, Scott AM, et al. The BREAST-Q: further validation in independent clinical samples. Plast Reconstr Surg. 2012;129:293–302.

    Article  PubMed  CAS  Google Scholar 

  20. Craft RO, Colakoglu S, Curtis MS, et al. Patient satisfaction in unilateral and bilateral breast reconstruction [outcomes article]. Plast Reconstr Surg. 2011;127:1417–24.

    Article  PubMed  CAS  Google Scholar 

  21. Cederna PS, Yates WR, Chang P, et al. Postmastectomy reconstruction: comparative analysis of the psychosocial, functional, and cosmetic effects of transverse rectus abdominis musculocutaneous flap versus breast implant reconstruction. Ann Plast Surg. 1995;35:458–68.

    Article  PubMed  CAS  Google Scholar 

  22. Alderman AK, Wilkins EG, Lowery JC, et al. Determinants of patient satisfaction in postmastectomy breast reconstruction. Plast Reconstr Surg. 2000;106:769–76.

    PubMed  CAS  Google Scholar 

  23. US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2006. http://www.fda.gov/ohrms/dockets/98fr/06d-0044-gdl0001.pdf. Accessed 5 Feb 2013.

  24. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.

    Google Scholar 

  25. Pusic A, Klassen A, Scott A, et al, editors. Feasibility and acceptability of patient-reported outcomes data collection for clinical care following breast reconstruction. Paper presented at American Society of Clinical Oncology Annual Meeting, Chicago; 2012.

  26. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.

  27. Pusic AL, Chen CM, Cano S, et al. Measuring quality of life in cosmetic and reconstructive breast surgery: a systematic review of patient-reported outcomes instruments. Plast Reconstr Surg. 2007;120:823–37.

    Article  PubMed  CAS  Google Scholar 

  28. McCarthy CM, Klassen AF, Cano SJ, et al. Patient satisfaction with postmastectomy breast reconstruction: a comparison of saline and silicone implants. Cancer. 2010;116:5584–91.

    Article  PubMed  Google Scholar 

  29. Gui GP, Kadayaprath G, Tan SM, et al. Long-term quality-of-life assessment following one-stage immediate breast reconstruction using biodimensional expander implants: the patient’s perspective. Plast Reconstr Surg. 2008;121:17–24.

    Article  PubMed  CAS  Google Scholar 

  30. Clough KB, O’Donoghue JM, Fitoussi AD, et al. Prospective evaluation of late cosmetic results following breast reconstruction: I. Implant reconstruction. Plast Reconstr Surg. 2001;107:1702–9.

    Article  PubMed  CAS  Google Scholar 

  31. Macadam SA, Ho AL, Cook EF Jr, et al. Patient satisfaction and health-related quality of life following breast reconstruction: patient-reported outcomes among saline and silicone implant recipients. Plast Reconstr Surg. 2010;125:761–71.

    Article  PubMed  CAS  Google Scholar 

  32. Hormes JM, Bryan C, Lytle LA, et al. Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology. 2010;43:1–13.

    PubMed  CAS  Google Scholar 

  33. Vassard D, Olsen MH, Zinckernagel L, et al. Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study. Eur J Cancer. 2010;46:3211–8.

    Article  PubMed  Google Scholar 

  34. Sagen A, Karesen R, Sandvik L, et al. Changes in arm morbidities and health-related quality of life after breast cancer surgery—a five-year follow-up study. Acta Oncol. 2009;48:1111–8.

    Article  PubMed  Google Scholar 

  35. Pusic AL, Cemal Y, Albornoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7:83–92.

    Article  PubMed  Google Scholar 

  36. Abbott A, Rueth N, Pappas-Varco S, et al. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol. 2011;18:3129–36.

    Article  PubMed  Google Scholar 

  37. Fisher CS, Martin-Dunlap T, Ruppel MB, et al. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Ann Surg Oncol. 2012;19:3246–50.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by the Cary Grossman Breast Research Fund. The BREAST-Q is available to clinicians and researchers at www.BREAST-Q.org.

Disclosure

The BREAST-Q is owned by Memorial Sloan-Kettering Cancer Center and the University of British Columbia. Dr. Pusic is a codeveloper of the BREAST-Q and receives a share of licensing revenues based on the inventor sharing policies of these two institutions. The other authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tari A. King MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koslow, S., Pharmer, L.A., Scott, A.M. et al. Long-Term Patient-Reported Satisfaction after Contralateral Prophylactic Mastectomy and Implant Reconstruction. Ann Surg Oncol 20, 3422–3429 (2013). https://doi.org/10.1245/s10434-013-3026-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3026-2

Keywords

Navigation